Control of oxidative reactions of hemoglobin in the design of blood substitutes: role of the ascorbate-glutathione antioxidant system.
Uncontrolled oxidative reactions of hemoglobin (Hb) are still the main unresolved problem for Hb-based blood substitute developers. Spontaneous oxidation of acellular ferrous Hb into a nonfunctional ferric Hb generates superoxide anion. Hydrogen peroxide, formed after superoxide anion dismutation, may react with ferrous/ferric Hb to produce toxic ferryl Hb, fluorescent heme degradation products, and/or protein-based free radicals. In the presence of free iron released from heme, superoxide anion and hydrogen peroxide might react via the Haber-Weiss and Fenton reactions to generate the hydroxyl radical. These highly reactive oxygen and heme species may not only be involved in shifting the cellular redox balance to the oxidized state that facilitates signal transduction and pro-inflammatory gene expression, but could also be involved in cellular and organ injury, and generation of vasoactive compounds such as isoprostanes and angiotensins. It is believed that these toxic species may be formed after administration of Hb-based blood substitutes, particularly in ischemic patients with a diminished ability to control oxidative reactions. Although varieties of antioxidant strategies have been suggested, this in vitro study examined the ability of the ascorbate-glutathione antioxidant system in preventing Hb oxidation and formation of its ferryl intermediate. The results suggest that although ascorbate is effective in reducing the formation of ferryl Hb, glutathione protects heme against excessive oxidation. Ascorbate without glutathione failed to protect the red blood cell membranes against Hb/hydrogen peroxide-mediated peroxidation. This study provides evidence that the ascorbate-glutathione antioxidant system is essential in attenuation of the pro-oxidant potential of redox active acellular Hbs, and superior to either ascorbate or glutathione alone.
Simoni
Jan
J
Department of Surgery, Texas Tech University Health Sciences Center, Lubbock, Texas, USA. jan.simoni@ttuhsc.edu
Villanueva-Meyer
Javier
J
Simoni
Grace
G
Moeller
John F
JF
Wesson
Donald E
DE
D000818:Animals; D001205:Ascorbic Acid / Q000494:pharmacology*; D001802:Blood Substitutes / Q000737:chemistry / Q000378:metabolism*; D002417:Cattle; D015195:Drug Design; D004910:Erythrocyte Membrane / Q000187:drug effects; D005978:Glutathione / Q000494:pharmacology*; D006418:Heme / Q000378:metabolism; D006801:Humans; D006861:Hydrogen Peroxide; D015227:Lipid Peroxidation / Q000187:drug effects; D010084:Oxidation-Reduction
D001802:Blood Substitutes; D006418:Heme; D006861:Hydrogen Peroxide; D005978:Glutathione; D001205:Ascorbic Acid